Literature DB >> 22367583

Diagnostics and treatment of the diabetic foot.

Jan Apelqvist1.   

Abstract

Every 30 s, a lower limb is amputated due to diabetes. Of all amputations in diabetic patients 85% are preceded by a foot ulcer which subsequently deteriorates to a severe infection or gangrene. There is a complexity of factors related to healing of foot ulcers including strategies for treatment of decreased perfusion, oedema, pain, infection, metabolic disturbances, malnutrition, non-weight bearing, wound treatment, foot surgery, and management of intercurrent disease. Patients with diabetic foot ulcer and decreased perfusion do often not have rest pain or claudication and as a consequence non-invasive vascular testing is recommended for early recognition of ulcers in need of revascularisation to achieve healing. A diabetic foot infection is a potentially limb-threatening condition. Infection is diagnosed by the presence or increased rate of signs inflammation. Often these signs are less marked than expected. Imaging studies can diagnose or better define deep, soft tissue purulent collections and are frequently needed to detect pathological findings in bone. The initial antimicrobial treatment as well as duration of treatment is empiric. There is a substantial delay in wound healing in diabetic foot ulcer which has been related to various abnormalities. Several new treatments related to these abnormalities have been explored in wound healing with various successes. An essential part of the strategy to achieve healing is an effective offloading. Many interventions with advanced wound management have failed due to not recognizing the need for effective offloading. A multidisciplinary approach to wounds and foot ulcer has been successfully implemented in different centres with a substantial decrease in amputation rate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367583     DOI: 10.1007/s12020-012-9619-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  179 in total

1.  Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients.

Authors:  Jan Apelqvist; Targ Elgzyri; Jan Larsson; Magnus Löndahl; Per Nyberg; Johan Thörne
Journal:  J Vasc Surg       Date:  2011-04-23       Impact factor: 4.268

2.  Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011.

Authors:  N C Schaper; G Andros; J Apelqvist; K Bakker; J Lammer; M Lepantalo; J L Mills; J Reekers; C P Shearman; R E Zierler; R J Hinchliffe
Journal:  Diabetes Metab Res Rev       Date:  2012-02       Impact factor: 4.876

3.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

Review 4.  Ischemic foot: definition, etiology and angiosome concept.

Authors:  C Setacci; G De Donato; F Setacci; E Chisci
Journal:  J Cardiovasc Surg (Torino)       Date:  2010-04       Impact factor: 1.888

Review 5.  Arterial imaging in patients with lower extremity ischemia and diabetes mellitus.

Authors:  Frank Pomposelli
Journal:  J Vasc Surg       Date:  2010-09       Impact factor: 4.268

6.  The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects.

Authors:  Victor Aboyans; Elena Ho; Julie O Denenberg; Lindsey A Ho; Loki Natarajan; Michael H Criqui
Journal:  J Vasc Surg       Date:  2008-08-09       Impact factor: 4.268

7.  Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot.

Authors:  J Apelqvist; K Bakker; W H van Houtum; N C Schaper
Journal:  Diabetes Metab Res Rev       Date:  2008 May-Jun       Impact factor: 4.876

Review 8.  Diabetes care for patients with peripheral arterial disease.

Authors:  M Heikkinen; M Salmenperä; A Lepäntalo; M Lepäntalo
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-03-26       Impact factor: 7.069

9.  Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers.

Authors:  T Kästenbauer; B Hörnlein; G Sokol; K Irsigler
Journal:  Diabetologia       Date:  2002-12-06       Impact factor: 10.122

10.  Optimal organization of health care in diabetic foot disease: introduction to the Eurodiale study.

Authors:  Leonne Prompers; Maya Huijberts; Jan Apelqvist; Edward Jude; Alberto Piaggesi; Karel Bakker; Michael Edmonds; Per Holstein; Alexandra Jirkovska; Didac Mauricio; Gunnel Ragnarson Tennvall; Heinrich Reike; Maximilian Spraul; Luigi Uccioli; Vilma Urbancic; Kristien Van Acker; Jeff Van Baal; Frits Van Merode; Nicolaas Schaper
Journal:  Int J Low Extrem Wounds       Date:  2007-03       Impact factor: 2.057

View more
  49 in total

1.  Selective blockade of estrogen receptor beta improves wound healing in diabetes.

Authors:  Vivekananda Gupta Sunkari; Ileana R Botusan; Octavian Savu; Jacob Grünler; Xiaowei Zheng; Jan-Åke Gustafsson; Kerstin Brismar; Sergiu-Bogdan Catrina
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

2.  Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.

Authors:  Eun Sook Kim; Sung Won Lee; Eun Young Mo; Sung Dae Moon; Je Ho Han
Journal:  Endocrine       Date:  2015-04-07       Impact factor: 3.633

3.  Cutaneous wound healing after treatment with plant-derived human recombinant collagen flowable gel.

Authors:  Shani Shilo; Sigal Roth; Tal Amzel; Tamar Harel-Adar; Eran Tamir; Frida Grynspan; Oded Shoseyov
Journal:  Tissue Eng Part A       Date:  2013-02-05       Impact factor: 3.845

4.  Prevention of diabetic foot ulceration: new evidences for an old problem.

Authors:  Luigi Uccioli
Journal:  Endocrine       Date:  2013-03-26       Impact factor: 3.633

5.  Diabetic foot in a patient with polydactyly.

Authors:  Yuxin Huang; Haidong Wang
Journal:  Endocrine       Date:  2014-02-08       Impact factor: 3.633

Review 6.  New vistas in the diagnosis of diabetic polyneuropathy.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Endocrine       Date:  2014-05-17       Impact factor: 3.633

7.  Multifactorial Experimental Design to Optimize the Anti-Inflammatory and Proangiogenic Potential of Mesenchymal Stem Cell Spheroids.

Authors:  Kaitlin C Murphy; Jacklyn Whitehead; Patrick C Falahee; Dejie Zhou; Scott I Simon; J Kent Leach
Journal:  Stem Cells       Date:  2017-03-27       Impact factor: 6.277

8.  Enhanced permeability responses to inflammation in streptozotocin-induced diabetic rat venules: Rho-mediated alterations of actin cytoskeleton and VE-cadherin.

Authors:  Dong Yuan; Sulei Xu; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

9.  Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial.

Authors:  Wen-Hao Tang; Fu-Huang Lin; Chien-Hsing Lee; Feng-Chih Kuo; Chang-Hsun Hsieh; Fone-Ching Hsiao; Yi-Jen Hung
Journal:  Endocrine       Date:  2013-06-18       Impact factor: 3.633

10.  Cultures of diabetic foot ulcers without clinical signs of infection do not predict outcomes.

Authors:  Sue E Gardner; Ambar Haleem; Ying-Ling Jao; Stephen L Hillis; John E Femino; Phinit Phisitkul; Kristopher P Heilmann; Shannon M Lehman; Carrie L Franciscus
Journal:  Diabetes Care       Date:  2014-07-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.